The isolation and identification of the copper protein from serum have clarified the problem of the nature of serum copper (1, 2) . This blue protein, ceruloplasmin, is an a-globulin with a molecular weight of approximately 151,000 and contains eight atoms of copper. Ceruloplasmin has true oxidase activity and since it acts on paraphenylene diamine and polyphenols but not on monophenols and monoamines, it has been classified as a laccase (3, 4) . Most if not all of the copper in normal human or pig serum is stated to be present in the form of this blue protein. The copper in serum obtained from pregnant women and from patients with infections and other diseases, like ceruloplasmin, is precipitated by 50 per cent saturation with ammonium sulfate. Furthermore, the ability of serum to oxidize paraphenylene diamine is proportional to the copper content not only in normal serum but also in serum obtained from the umbilical vein, from pregnant women and from patients with infections (5). Presumably then, in patients with hypercupremia the copper is in the form of ceruloplasmin.
The problem still remains as to whether or not ceruloplasmin serves the function of transporting newly absorbed copper from the gastro-intestinal mucosa to the liver. Since the concentration of copper (ceruloplasmin) in normal human serum is relatively constant and is not influenced by meals or by the ingestion of copper (6) (7) (8) , it seems unlikely that this protein is concerned in the active transport of copper. More important is the observation (1) that the copper in ceruloplasmin does not react directly with sodium diethyldithiocarbamate, whereas copper added to serum in sitro does react directly with this reagent (9) . This would indicate that, unlike the ability of serum to bind iron, there is no reserve capacity of normal serum to bind additional amounts of copper in the form of ceruloplasmin. It would also seem unlikely that newly absorbed copper would be transported to the liver in the form of an active enzyme.
It has been demonstrated (10) that the crystalline 8,, metal-binding globulin (transferrin) isolated from plasma interacts with copper at pH 7.4 although maximal binding occurs at pH 8.5 . At pH 7.4 iron readily replaces copper and copper cannot replace iron. It has been suggested that this protein may be concerned in transporting newly absorbed copper to the liver (10) . Observations made by Holmberg and Laurell (1), however, suggest that the metal-binding protein does not function in the transportation of copper. The purpose of this paper is to present data concerning the type of binding of copper added both in vivo and in vitro to plasma of normal and abnormal human subjects as well as to that of rats, pigs and dogs. Data are also presented on the relation of erythrocyte copper to plasma copper.
This work has been in progress since 1949 and two preliminary reports have been published (8, 11) .
METHODS
Plasma and red cell copper determinations were performed by the method developed in this laboratory (12) . The copper in plasma which reacts with sodium diethyldithiocarbamate when this reagent is added directly to plasma is referred to as the "direct-reacting" copper fraction. The difference between the total plasma copper determined following the liberation of the copper from the protein by acid and the direct-reacting copper is referred to as the "indirect-reacting" fraction.
The direct-reacting fraction of plasma copper was measured by adding 0.5 ml. of a saturated solution of sodium pyrophosphate and 2.5 ml. of redistilled water to 1.0 ml. of plasma. The Adult male rats of the Sprague-Dawley strain were used in this study. One-tenth ml. of turpentine (Rexall Rectified Oil of Turpentine, U.S.P.) was injected in order to produce a sterile intramuscular abscess (13) . Weanling rats were made deficient in copper by feeding a condensed milk diet supplemented with iron (14) . Blood was withdrawn from the abdominal aorta and potassium oxalate was used as an anticoagulant.
RESULTS
Plasma copper. Total plasma copper and direct-reacting copper measurements were made on human, rat, dog and pig plasma and the results are presented in Table I . ' plasma from normal dogs and pigs the directreacting fraction was higher than in man and rats, being 12 and 42 per cent of the total copper, respectively.
The rate at which the copper combines with the carbamate reagent was studied in human, rat, dog and pig plasma. As can be seen in Figure 1 , the reaction rate varied markedly between the species. The rate was slowest in human and rat plasma and most rapid in pig plasma.
Copper added to plasma in sitro. Amounts of copper ranging from 100 to 800 ug. per 100 ml. were added in vitro to human, rat, dog and pig plasma and measurements were made of the reactivity of the copper added. The results are presented in Table II .
In human, dog and pig plasma all of the copper added could be accounted for in the direct-reacting fraction. This was true for both normal human plasma and hypercupremic pregnancy plasma and was independent of the amount of copper added or the initial level. In all three species, the direct-reacting fraction was greater than the amount of copper added. This discrepancy was consistent and was greater than could be accounted for in the error of the method. Thus it would appear that the addition of copper caused a portion of the original indirect-reacting copper to react directly. In The rate at which added copper reacted with carbamate is shown in Figure 1 . The rate was exceedingly rapid in dog and pig plasma, complete reaction taking place within five minutes. The curves for rat and human plasma are hyperbolic in shape and level off in 20 to 30 minutes. The rate was somewhat faster in rat plasma than in human plasma. In human plasma no significant difference in rate was observed when normal, The influence of pH on the dialyzability of native plasma copper (indirect-reacting) and on the dialyzability of copper added to plasma in sitro (direct-reacting) was studied in order to determine if the two types of copper binding could be differentiated in this manner. The results are presented in Figure 2 . It will be seen that no copper dialyzed from the native plasma within the pH range of 6 to 11. Below pH 6 the copper became dialyzable. On the other hand, copper added to plasma seemed to be more labile and was dialyzable above pH 9 and below pH 7.
Plasma copper after the oral administration of copper. Two hundred and fifty mg. of Cupralene, containing approximately 50 mg. of copper, were administered orally to each of three fasting normal human subjects. Attempts to study blood copper changes, at intervals after the ingestion of copper sulfate or copper acetate in doses of 150 to 200 mg., met with failure because of the emetic action of these inorganic compounds. The ingestion of the above dose of Cupralene was followed by nausea and mild, transient abdominal cramps, but not by vomiting. The changes in plasma and red cell copper after the administration of Cupralene are shown in Figure 3 .
In none of the three subjects given Cupralene orally was there a significant change in the plasma The erythrocyte copper values were not so uniformly stable but no significant or consistent increase in direct-reacting copper could be detected in the eight hour period.
A dog was given 165 mg. of copper per kg. of body weight in the form of copper sulfate in a single oral dose in order to study the type of binding of copper which is in the process of transportation to the liver. This amount of copper sulfate caused vomiting and death of the dog four hours later. The changes in total plasma copper, directreacting copper, and red cell copper are shown in Figure 4 .
A considerable amount of copper was absorbed, as evidenced by the increase in the plasma copper level from 100,ug. per 100 ml. to 910 pg. per 100 ml. in 40 minutes. All of the copper appearing in the plasma reacted directly with carbamate. More surprising was the fact that the red cell copper level increased from 75 pg. per 100 ml. to 2800 pg.
per 100 ml. During the period 40 to 140 minutes after the copper was given, the red cell copper continued to increase while the plasma copper level decreased from 900 to 360 pg. per 100 ml. Approximately two hours after the copper was given, 89 per cent of the copper in the blood was in the erythrocytes and only 11 per cent was in the plasma.
Plasma copper after the intravenous administration of copper. In order to study the form in which copper is transported in blood after the intravenous administration of copper, Cupralene was administered intravenously to three normal human subjects and to one dog. Seven dogs were given copper sulfate intravenously. The results are summarized in Table III . In the human subject, 90 per cent of the copper which appeared in 0 Xa the plasma after the administration of Cupralene reacted directly with carbamate. In the dog, all of the copper in the plasma after the administration of copper sulfate reacted directly with carbamate. Apparently, as a result of experimental error, the mean direct-reacting copper was slightly greater than the total plasma copper.
The changes in total plasma copper, direct-reacting copper, and red cell copper at various intervals of time after intravenous administration of copper are shown in detail in Figure 5 copper pg./100 ml.
The determinations were made in three normal human subjects after the i. Following the administration of Cupralene to the human subject ( Figure 5 ) or a dog ( Figure  6 ), the rate of clearance of the copper from the plasma was rapid and complete in about four hours even though the initial ten minute levels were above 400 jug. per 100 ml. This rapid decrease was due to a decrease in the direct-reacting fraction. A significant increase in red cell copper was observed in both species. In crease occurred within ten minutes after the injection. The red cell copper returned slowly to the baseline value during the first 24 hours. In the dog the red cell copper increase was maximal one hour after the injection and returned to the baseline value within three hours after the injection. The rate of removal from the plasma of intravenously injected copper sulfate was more rapid than the removal of Cupralene. In the dog, following the administration of copper sulfate the plasma copper level rose above 700 ug. per 100 ml. and decreased to near the baseline value within 30 minutes. There was a considerably greater and earlier increase in red cell copper following the administration of copper sulfate to dogs than following the administration of Cupralene. Thus The measurements were made 15 minutes after the addition of copper. the red cell membrane appears to be more permeable to this inorganic compound than to the organic compound, Cupralene.
Copper albumin and copper f3, metal-binding globulin. Since it has been suggested that copper may be transported by being bound to albumin (15) or to the I,A metal-binding globulin (10), and since the data presented above indicate that copper added to plasma is not bound in the same manner as the native plasma copper, the combination of copper with bovine serum albumin and human metal-binding globulin (Cohn fraction IV-7) was studied. The results are presented in Table IV . Eighty-eight to 91 per cent of the copper combined with either of these proteins reacted directly with-carbamate.
The transfer of copper between cells and plasma. When copper is added to plasma and the plasma is incubated with red cells, there is an appreciable movement of copper into the red cells. The partition of copper betveen plasma and red ceUs after the addition of copper Increasing quantities of a solution of copper sulfate (1000 ug./ml.) were added to 10 ml. aliquots of pooled rat blood (V.P.R.C., 48 ml./100 ml.). The miixture was incubated at 370 C for four hours. The results are expressed in ;pg. of added copper recovered in the plasma and the cells. The failure of columns (2) and (3) the ratio of plasma copper: cell copper remained constant at about 6: 1 when more than 20 ug. of copper were added.
As shown in Figure 8 , when copper sulfate is injected intravenously into a dog and a sample of blood is removed and incubated at 370 C., there is a rather rapid shift of copper from the plasma into the cells. The same is true, as shown in Table VI , Exper. D, when Cupralene is injected into a human subject and a sample of blood is removed and incubated at 50 C. However, when cells containing an increased amount of copper are incubated with plasma containing a normal amount of copper (Table VI pig plasma, respectively, has been identified by Holmberg and Laurell (1, 2) as a copper a-globulin. It is primarily this fraction which increases in such conditions as pregnancy, acute leukemia, infections and other pathological conditions in human subjects (1, 5, 16, 17) and following experimentally induced fever in animals (14) .
The remainder of the copper in plasma is in a form which reacts directly with sodium diethyldithiocarbamate but which, like the indirectreacting fraction, is also not dialyzable at pH 7.5. The specific protein or proteins to which this fraction of the copper is bound are not known. Copper combined with serum albumin or with the ft, metal-binding globulin is likewise not dialyzable within the physiologic pH range 4 and reacts directly with carbamate. Therefore, it is possible that the direct-reacting copper fraction in plasma is bound to either or both of these proteins. The data of Holmberg and Laurell (1) suggest, however, that the metal-binding globulin does not function in this capacity. Since one of the most interesting aspects of the chemistry of copper is its ability to form complexes and to form simultaneous links to the same organic molecules, the so-called "chelation" phenomenon (18, 19) , it would not be surprising if the direct-reacting copper is bound to several different proteins rather than to a specific copper-transporting protein such as is the case with iron (10) .
From our observations and from those of Holmberg and Laurell (1-5) a concept of the functional significance of these two types of copper in plasma may be derived.
It seems unlikely that ceruloplasmin (indirectreacting fraction) serves to transport newly absorbed copper from the gastro-intestinal tract to the liver. Thus, this fraction remains relatively constant in normal human subjects and animals and is not influenced by the addition of copper to plasma or by the oral or intravenous administration of copper. Again, even in plasma of low copper content (obtained from animals deficient in copper) there is no reserve capacity to bind copper in this form. Since this copper protein has oxidase activity, it apparently represents a circulating copper-containing enzyme which is normally present in plasma and which increases in certain pathological situations.
'Unpublished observations.
On the other hand, following the addition of copper to plasma, or following the oral or intravenous administration of copper to dogs and the intravenous administration of copper to human subjects, there is a striking increase in the directreacting copper fraction. This would seem to indicate that it is this fraction which is actively concerned in the transportation of copper to the principal storage site, namely, the liver. Since normally only small quantities of copper are absorbed daily (8) and since copper is rapidly removed from the plasma, it is not surprising that under normal circumstances this fraction represents only a small portion of the total circulating copper.
The possible role of the red cell in the transportation of copper needs mention. It is obvious from the experiments reported here that when large amounts of copper are given either orally or intravenously, a significant portion of the copper is taken up by the cells. However, since the amounts of copper given far exceeded the physiologic range and since the administration of even as much as 50 mg. of copper orally in a single dose to human subjects was not associated with a significant increase in erythrocyte copper, it would seem that this mechanism is of no physiologic importance. The amount of copper in red cells is exceedingly constant in human subjects even under pathologic circumstances associated with an increase in plasma copper (6, 16) .
It is interesting to consider the striking differences between plasma iron and plasma copper. Plasma iron represents iron in the process of transportation from one site to another and is combined with a specific protein, the sole or, at least, the primary function of which is to transport the iron (10) . Under normal circumstances only about one-third of this protein is bound to iron (20) (21) (22) so that there is a considerable capacity held in reserve. The administration of relatively small amounts of iron orally is associated with a detectable increase in the plasma iron level (23) . Iron administered intravenously is removed relatively slowly over a period of 8 to 24 hours (23) .
The situation in regard to copper is quite different. Normally only a very small fraction of plasma copper represents copper in an inactive form in the process of transportation (to sites. where it is to be converted into a functioning enzyme). The greater part of the circulating copper is in the form of an active enzyme. The administration of relatively large amounts of copper orally is not associated with an increase in the plasma copper level, apparently because copper in the form in which it is bound in plasma after absorption (direct-reacting) is removed from the circulation at a rate greater than it can be absorbed.
SUMMARY
Evidence is presented that copper is present in human, rat, dog and pig plasma in at least two different forms. The fraction which reacts with sodium diethyldithiocarbamate only after removal from the protein by treatment with hydrochloric acid corresponds to the copper a-globulin (ceruloplasmin) isolated by Holmberg and Laurell. This fraction constitutes approximately 96, 99, 88 and 58 per cent of the copper normally present in human, rat, dog and pig plasma, respectively. The remainder of the copper in plasma is in a form which reacts directly with the carbamate reagent but, like the indirect-reacting fraction, is also nondialyzable within the physiologic pH range. The hypercupremia of pregnancy and that in infections in human subjects and in association with experimentally induced infections in animals, is due to an increase in the indirect-reacting fraction. The hypercupremia which follows the oral or intravenous administration of copper is due to an increase in the direct-reacting fraction.
